title: Abciximab: a reappraisal of its use in coronary care.
abstract: Platelet reactivity plays a pivotal role in the pathogenesis of ischemic adverse events during and after acute coronary syndromes (ACS), and percutaneous coronary intervention (PCI). Glycoprotein (GP) IIb/IIIa inhibitors are the strongest antiplatelet agents currently available on the market and three different compounds, namely abciximab, tirofiban, and eptifibatide, have been approved for clinical use. Abciximab has been investigated in the clinical field far more extensively than the other GPIIb/IIIa inhibitors. Abciximab is an anti-integrin Fab fragment of a human - mouse chimeric monoclonal antibody with high affinity and a slow dissociation rate from the GP IIb/IIIa platelet receptor. Abciximab, given shortly before the coronary intervention, is superior to placebo in reducing the acute risk of ischemic complications (EPIC, EPISTENT, EPILOG trials); moreover, in the ISAR-REACT 2 study abciximab has been shown to reduce the risk of adverse events in patients with non ST-segment elevation ACS who are undergoing PCI even after optimal pre-treatment with 600 mg of clopidogrel. Finally, abciximab has been also used in abciximab-coated stent, with only bolus administration regimen and for direct intracoronary use with promising results that may extend and/or modify its current use in clinical practice in future.
authors.affiliation: Cardiovascular Institute, Azienda Ospedaliera Universitaria S. Anna, Ferrara, Italy and Cardiovascular Research Centre, Salvatore Maugeri Foundation, IRCCS Gussago (BS), Italy.
authors.forename: Marco
authors.initials: M
authors.lastname: Valgimigli
authors.forename: Gianluca
authors.initials: G
authors.lastname: Campo
authors.forename: Matteo
authors.initials: M
authors.lastname: Tebaldi
authors.forename: Roberto
authors.initials: R
authors.lastname: Carletti
authors.forename: Chiara
authors.initials: C
authors.lastname: Arcozzi
authors.forename: Roberto
authors.initials: R
authors.lastname: Ferrari
authors.forename: Gianfranco
authors.initials: G
authors.lastname: Percoco
references.citation: Chest. 2005 Feb;127(2 Suppl):53S-59S
references.pmid: 15706031
references.citation: N Engl J Med. 2004 Jan 15;350(3):232-8
references.pmid: 14724302
references.citation: Circulation. 2003 Nov 11;108(19):e138; author reply e138
references.pmid: 14610001
references.citation: Clin Ther. 2003 Jan;25(1):225-34
references.pmid: 12637122
references.citation: J Am Coll Cardiol. 2006 Feb 7;47(3):522-8
references.pmid: 16458130
references.citation: Lancet. 1997 May 17;349(9063):1429-35
references.pmid: 9164316
references.citation: J Am Coll Cardiol. 2006 Feb 7;47(3):685-6
references.pmid: 16458158
references.citation: JAMA. 2005 May 4;293(17):2109-17
references.pmid: 15870414
references.citation: N Engl J Med. 1998 Aug 13;339(7):436-43
references.pmid: 9705684
references.citation: Lancet. 1999 Jan 16;353(9148):227-31
references.pmid: 9923894
references.citation: Circulation. 1997 Sep 2;96(5):1445-53
references.pmid: 9315530
references.citation: J Invasive Cardiol. 2006 Nov;18(11):521-6
references.pmid: 17090813
references.citation: J Am Coll Cardiol. 2006 Mar 7;47(5):933-8
references.pmid: 16516074
references.citation: J Pharmacol Exp Ther. 2003 Dec;307(3):969-76
references.pmid: 14534354
references.citation: Mayo Clin Proc. 2007 Feb;82(2):196-202
references.pmid: 17290727
references.citation: J Am Coll Cardiol. 2000 Mar 15;35(4):915-21
references.pmid: 10732888
references.citation: J Am Coll Cardiol. 2002 Oct 2;40(7):1366-74
references.pmid: 12383588
references.citation: Eur Heart J. 2007 Jul;28(13):1598-660
references.pmid: 17569677
references.citation: Am J Cardiol. 2004 Oct 15;94(8):1050-4
references.pmid: 15476624
references.citation: N Engl J Med. 2001 Jun 21;344(25):1895-903
references.pmid: 11419426
references.citation: Circulation. 2002 Sep 17;106(12):1470-6
references.pmid: 12234950
references.citation: Eur Heart J. 2005 Apr;26(8):804-47
references.pmid: 15769784
references.citation: N Engl J Med. 1997 Jun 12;336(24):1689-96
references.pmid: 9182212
references.citation: Am J Cardiol. 2003 Apr 1;91(7):876-8
references.pmid: 12667577
references.citation: J Am Coll Cardiol. 2004 Sep 15;44(6):1187-93
references.pmid: 15364318
references.citation: Circulation. 2006 Dec 12;114(24):2636-43
references.pmid: 17145988
references.citation: Am Heart J. 2006 Nov;152(5):876-81
references.pmid: 17070148
references.citation: Am J Ther. 2004 Jul-Aug;11(4):302-7
references.pmid: 15266223
references.citation: N Engl J Med. 2006 Nov 23;355(21):2203-16
references.pmid: 17124018
references.citation: Circulation. 2004 Jun 29;109(25):3171-5
references.pmid: 15184279
references.citation: Am J Cardiol. 2002 Dec 15;90(12):1421-3
references.pmid: 12480064
references.citation: Lancet. 1998 Jul 11;352(9122):87-92
references.pmid: 9672272
references.citation: J Am Coll Cardiol. 2006 Dec 5;48(11):2178-85
references.pmid: 17161242
references.citation: Lancet. 2001 Jun 16;357(9272):1915-24
references.pmid: 11425411
references.citation: J Am Coll Cardiol. 2007 Aug 14;50(7):e1-e157
references.pmid: 17692738
references.citation: Drugs. 2005;65(3):313-24
references.pmid: 15669877
references.citation: Circulation. 2001 Jul 10;104(2):181-6
references.pmid: 11447083
references.citation: JAMA. 2006 Apr 5;295(13):1531-8
references.pmid: 16533938
references.citation: N Engl J Med. 2001 Jun 21;344(25):1888-94
references.pmid: 11419425
references.citation: Am J Cardiol. 2004 Jul 1;94(1):35-9
references.pmid: 15219505
references.citation: J Clin Pharm Ther. 2004 Dec;29(6):497-510
references.pmid: 15584937
references.citation: N Engl J Med. 1998 May 21;338(21):1488-97
references.pmid: 9599103
references.citation: J Am Coll Cardiol. 2003 Dec 3;42(11):1879-85
references.pmid: 14662245
references.citation: N Engl J Med. 1994 Apr 7;330(14):956-61
references.pmid: 8121459
references.citation: JAMA. 2007 Feb 14;297(6):591-602
references.pmid: 17299194
references.citation: Circulation. 2003 Apr 15;107(14):1840-3
references.pmid: 12682003
references.citation: J Thromb Thrombolysis. 2003 Apr;15(2):71-80
references.pmid: 14618072
references.citation: Eur Heart J. 2007 Feb;28(4):443-9
references.pmid: 17251257